Value-based tiered pricing for universal health coverage: an idea worth revisiting

Kalipso Chalkidou, Karl Claxton, Rachel Silverman, Prashant Yadav

Research output: Contribution to journalArticlepeer-review


The pricing of medicines and health products ranks among the most hotly debated topics in health policy, generating controversy in richer and poorer markets alike. Creating the right pricing structure for pharmaceuticals and other healthcare products is particularly important for low- and middle-income countries, where pharmaceuticals account for a significant portion of total health expenditure; high medicine prices therefore threaten the feasibility and sustainability of nascent schemes for universal health coverage (UHC). We argue that a strategic system of value-based tiered pricing (VBTP), wherein each country would pay a price for each health product commensurate with the local value it provides, could improve access, enhance efficiency, and empower countries to negotiate with product manufacturers. This paper attempts to further understanding on the potential value of tiered pricing, barriers to its implementation, and potential strategies to overcome those.

Original languageEnglish
Pages (from-to)16
JournalGates open research
Publication statusAccepted/In press - 21 Feb 2020

Bibliographical note

© 2020 Chalkidou K et al.

Cite this